每年專案
個人檔案
學歷
- 2002 臺大醫學院藥理學研究所博士
- 1994 臺北醫學大學醫學研究所碩士
經歷
- 2020- 臺北醫學大學醫學科技學院副院長
- 2019- 臺北醫學大學新藥研發產業博士學位學程主任
- 2018- 臺北醫學大學癌症生物學與藥物研發研究所教授
- 2016-2018 臺北醫學大學癌症生物學與藥物研發博士學位學程教授
- 2013-2016 臺北醫學大學癌症生物學與藥物研發博士學位學程副教授
- 2008-2013 臺北醫學大學藥理學科助理教授
- 2009-2013 國家衛生研究院助理研究員
- 2007-2009 臺大醫學院助研究員
- 2002-2007 臺大醫學院博士後研究
- 1994-1998 長庚大學醫學系助教
研究興趣
- 藥物研發
- 疾病動物模式
- 藥理藥效學
URL
獎項
- 2019 臺北醫學大學單一研究計畫經費獎
指紋
- 12 類似的個人檔案
網路
專案
-
-
The Role of Protein Kinase CK1 and The Mechanism of Inhibitors on Glioblastoma Cells
7/1/20 → 2/1/21
研究計畫: A - 政府部門 › b - 科技部
-
-
-
研究成果
-
Erratum: TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis (Theranostics (2019) 9:22 (6676-6689) DOI: 10.7150/thno.34020)
Huang, H. L., Liu, Y. M., Sung, T. Y., Huang, T. C., Cheng, Y. W., Liou, J. P. & Pan, S. L., 一月 1 2021, 於: Theranostics. 11, 5, p. 2079 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach
Chao, M. W., Lin, T. E., HuangFu, W. C., Chang, C. D., Tu, H. J., Chen, L. C., Yen, S. C., Sung, T. Y., Huang, W. J., Yang, C. R., Pan, S. L. & Hsu, K. C., 十二月 2021, 於: Journal of Enzyme Inhibition and Medicinal Chemistry. 36, 1, p. 98-108 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia
Yen, S. C., Chen, L. C., Huang, H. L., Ngo, S. T., Wu, Y. W., Lin, T. E., Sung, T. Y., Lien, S. T., Tseng, H. J., Pan, S. L., Huang, W. J. & Hsu, K. C., 一月 22 2021, 於: Journal of Natural Products. 84, 1, p. 1-10 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors
Hsu, K. C., HuangFu, W. C., Lin, T. E., Chao, M. W., Sung, T. Y., Chen, Y. Y., Pan, S. L., Lee, J. C., Tzou, S. C., Sun, C. M. & Yang, J. M., 六月 29 2020, 於: Scientific Reports. 10, 1, p. 10510 10510.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors
Chang, F. L., Tsai, K. C., Lin, T. Y., Yang, T. W., Lo, Y. N., Chen, W. C., Chang, J. H., Lu, M. K., Chiou, C. T., Chen, P. H., Yen, Y., Pan, S. L. & Lee, Y. C., 一月 1 2020, 於: BioMed Research International. 2020, 3415471.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取5 引文 斯高帕斯(Scopus)
資料集
-
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Contributor), Liou, J. (Contributor), Teng, C. (Contributor) & Pan, S. (Contributor), Unknown Publisher, 五月 29 2019
DOI: 10.6084/m9.figshare.c.4522856.v1, https://doi.org/10.6084%2Fm9.figshare.c.4522856.v1
資料集: Dataset
-
Additional file 2: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Contributor), Liou, J. (Contributor), Teng, C. (Contributor) & Pan, S. (Contributor), Unknown Publisher, 五月 29 2019
DOI: 10.6084/m9.figshare.8202887.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202887/1
資料集: Dataset
-
Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Contributor), Liou, J. (Contributor), Teng, C. (Contributor) & Pan, S. (Contributor), Unknown Publisher, 五月 29 2019
DOI: 10.6084/m9.figshare.8202902.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202902/1
資料集: Dataset
-
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Tu, H. (Contributor), Lin, Y. (Contributor), Chao, M. (Contributor), Sung, T. (Contributor), Wu, Y. (Contributor), Chen, Y. (Contributor), Lin, M. (Contributor), Liou, J. (Contributor), Pan, S. (Contributor) & Yang, C. (Contributor), Unknown Publisher, 十二月 29 2018
DOI: 10.6084/m9.figshare.c.4350887.v1, https://springernature.figshare.com/collections/The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/4350887/1
資料集: Dataset
-
Additional file 1 of Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Lin, C. (Contributor), Hsu, K. (Contributor), HuangFu, W. (Contributor), Lin, T. E. (Contributor), Huang, H. (Contributor) & Pan, S. (Contributor), Unknown Publisher, 三月 12 2020
DOI: 10.6084/m9.figshare.11992497.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Investigating_the_potential_effects_of_selective_histone_deacetylase_6_inhibitor_ACY1215_on_infarct_size_in_rats_with_cardiac_ischemia-reperfusion_injury/11992497/1
資料集: Dataset